Fig. 4From: A robust multiplex immunoaffinity mass spectrometry assay (PromarkerD) for clinical prediction of diabetic kidney diseaseInter-laboratory comparison. Scatter plot of the correlation between the development laboratory and an independent comparison laboratory with the immunoaffinity method (IAMS) after individual biomarker Bland–Altman analyses between the laboratories. Slope of the line of equality is 1Back to article page